266 related articles for article (PubMed ID: 20545975)
1. NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma.
Watanabe M; Kono K; Kawaguchi Y; Mizukami Y; Mimura K; Maruyama T; Izawa S; Fujii H
Dis Esophagus; 2010 Nov; 23(8):675-81. PubMed ID: 20545975
[TBL] [Abstract][Full Text] [Related]
2. H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.
Izawa S; Kono K; Mimura K; Kawaguchi Y; Watanabe M; Maruyama T; Fujii H
Cancer Immunol Immunother; 2011 Dec; 60(12):1801-10. PubMed ID: 21811786
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma.
Kawaguchi Y; Kono K; Mimura K; Sugai H; Akaike H; Fujii H
Int J Cancer; 2007 Feb; 120(4):781-7. PubMed ID: 17096332
[TBL] [Abstract][Full Text] [Related]
4. FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.
Taylor RJ; Chan SL; Wood A; Voskens CJ; Wolf JS; Lin W; Chapoval A; Schulze DH; Tian G; Strome SE
Cancer Immunol Immunother; 2009 Jul; 58(7):997-1006. PubMed ID: 18979096
[TBL] [Abstract][Full Text] [Related]
5. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
[TBL] [Abstract][Full Text] [Related]
6. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma.
Watanabe M; Kono K; Kawaguchi Y; Mizukami Y; Mimura K; Maruyama T; Fujii H
Br J Cancer; 2010 Feb; 102(3):520-9. PubMed ID: 20029417
[TBL] [Abstract][Full Text] [Related]
8. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Soofi M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):193-8. PubMed ID: 20404389
[TBL] [Abstract][Full Text] [Related]
11. IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.
Roberti MP; Barrio MM; Bravo AI; Rocca YS; Arriaga JM; Bianchini M; Mordoh J; Levy EM
Breast Cancer Res Treat; 2011 Nov; 130(2):465-75. PubMed ID: 21308409
[TBL] [Abstract][Full Text] [Related]
12. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
[TBL] [Abstract][Full Text] [Related]
13. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
[TBL] [Abstract][Full Text] [Related]
14. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S
Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448
[TBL] [Abstract][Full Text] [Related]
15. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
17. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
[TBL] [Abstract][Full Text] [Related]
19. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
20. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
